X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3675) 3675
Publication (362) 362
Book Review (46) 46
Newsletter (20) 20
Magazine Article (17) 17
Conference Proceeding (8) 8
Book Chapter (7) 7
Newspaper Article (6) 6
Dissertation (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2736) 2736
minocycline - therapeutic use (2374) 2374
male (1608) 1608
minocycline (1484) 1484
index medicus (1478) 1478
anti-bacterial agents - therapeutic use (1450) 1450
female (1324) 1324
animals (984) 984
adult (901) 901
middle aged (798) 798
minocycline - pharmacology (782) 782
minocycline - analogs & derivatives (724) 724
pharmacology & pharmacy (675) 675
treatment outcome (529) 529
aged (522) 522
microbiology (511) 511
minocycline - administration & dosage (485) 485
anti-bacterial agents - pharmacology (469) 469
infectious diseases (460) 460
minocycline - adverse effects (458) 458
mice (413) 413
neurosciences (410) 410
microbial sensitivity tests (384) 384
adolescent (357) 357
rats (351) 351
antibiotics (346) 346
tigecycline (339) 339
drug therapy, combination (325) 325
disease models, animal (320) 320
anti-bacterial agents - adverse effects (313) 313
anti-bacterial agents - administration & dosage (308) 308
infections (276) 276
dermatology (268) 268
research (256) 256
inflammation (251) 251
health aspects (243) 243
microglia (234) 234
drug therapy (219) 219
clinical neurology (218) 218
acne vulgaris - drug therapy (216) 216
therapy (209) 209
immunology (205) 205
tetracyclines (204) 204
time factors (202) 202
care and treatment (201) 201
analysis (200) 200
tetracyclines - therapeutic use (196) 196
doxycycline (186) 186
child (183) 183
tetracycline (182) 182
disease (176) 176
drug resistance, multiple, bacterial (173) 173
aged, 80 and over (171) 171
neuroprotective agents - therapeutic use (168) 168
double-blind (166) 166
follow-up studies (165) 165
efficacy (162) 162
microglia - drug effects (160) 160
rats, sprague-dawley (160) 160
bacteria (151) 151
microglial activation (149) 149
neuroprotection (149) 149
research article (147) 147
activation (146) 146
medicine, general & internal (146) 146
young adult (146) 146
dentistry, oral surgery & medicine (145) 145
doxycycline - therapeutic use (144) 144
brain (143) 143
in-vitro (140) 140
rifampin - therapeutic use (139) 139
article (137) 137
expression (136) 136
dose-response relationship, drug (132) 132
mouse model (132) 132
retrospective studies (132) 132
administration, oral (131) 131
acinetobacter baumannii - drug effects (130) 130
acinetobacter infections - drug therapy (130) 130
bacterial infections - drug therapy (129) 129
double-blind method (129) 129
neurology (129) 129
clinical trials as topic (128) 128
medicine (127) 127
rodents (127) 127
drug resistance (125) 125
surgery (125) 125
apoptosis (124) 124
clinical trials (124) 124
drug resistance, bacterial (124) 124
dosage and administration (123) 123
risk factors (120) 120
susceptibility (119) 119
oncology (115) 115
pneumonia (113) 113
tetracycline - therapeutic use (113) 113
infectious disease (110) 110
rats, wistar (110) 110
drug combinations (109) 109
minocycline - pharmacokinetics (109) 109
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3387) 3387
Japanese (107) 107
French (78) 78
German (39) 39
Spanish (31) 31
Chinese (22) 22
Italian (22) 22
Dutch (12) 12
Russian (6) 6
Czech (5) 5
Turkish (4) 4
Hebrew (3) 3
Danish (1) 1
Finnish (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 2017, Volume 61, Issue 10
Journal Article
Journal of Endodontics, ISSN 0099-2399, 2009, Volume 35, Issue 10, pp. 1343 - 1349
Abstract Introduction Several case reports on endodontic regeneration involving immature permanent teeth have recently been published. These case series have... 
Endocrinology & Metabolism | Dentistry | retrospective studies | regenerative endodontics | revascularization | Immature teeth | MIXTURE | MINOCYCLINE | TOOTH | PULP REVASCULARIZATION | MINERAL TRIOXIDE AGGREGATE | PERMANENT TEETH | DENTIN | DENTISTRY, ORAL SURGERY & MEDICINE | APICAL PERIODONTITIS | METRONIDAZOLE | CIPROFLOXACIN | Formocresols - therapeutic use | Follow-Up Studies | Apexification | Humans | Dental Pulp Cavity - diagnostic imaging | Dental Pulp Necrosis - therapy | Silicates - therapeutic use | Aluminum Compounds - therapeutic use | Anti-Bacterial Agents - therapeutic use | Dental Pulp - diagnostic imaging | Odontometry - methods | Calcium Compounds - therapeutic use | Guided Tissue Regeneration - methods | Dentinogenesis - physiology | Minocycline - administration & dosage | Retrospective Studies | Dental Pulp - physiopathology | Dentin - diagnostic imaging | Oxides - therapeutic use | Dentin - physiopathology | Root Canal Therapy | Metronidazole - administration & dosage | Dental Pulp Cavity - physiopathology | Root Canal Irrigants - therapeutic use | Treatment Outcome | Image Processing, Computer-Assisted - methods | Root Canal Filling Materials - therapeutic use | Tooth Apex - diagnostic imaging | Radiography | Ciprofloxacin - administration & dosage | Calcium Hydroxide - therapeutic use | Tooth Cervix - diagnostic imaging | Dental Pulp Necrosis - diagnostic imaging | Odontogenesis - physiology | Anti-Bacterial Agents - administration & dosage | Drug Combinations | Tooth Apex - physiopathology | Analysis | Root canal therapy
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2015, Volume 59, Issue 10, pp. 5903 - 5908
New antibiotic options are urgently needed for the treatment of carbapenem-resistant Enterobacteriaceae infections. We report a 64-year-old female with... 
URINARY-TRACT-INFECTIONS | THERAPY | IMIPENEM | EFFICACY | BETA-LACTAMASE | CEFTAZIDIME-AVIBACTAM | BLOOD-STREAM | REGIMEN | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | OUTCOMES | ENTEROBACTERIACEAE | Klebsiella pneumoniae - drug effects | Klebsiella Infections - pathology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Minocycline - analogs & derivatives | Ganciclovir - analogs & derivatives | Colectomy | beta-Lactamases - biosynthesis | Intestine, Small - transplantation | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Minocycline - therapeutic use | Drug Resistance, Multiple, Bacterial | Ganciclovir - therapeutic use | Azabicyclo Compounds - therapeutic use | Colistin - therapeutic use | Female | Thienamycins - therapeutic use | Klebsiella Infections - drug therapy | Antiviral Agents - therapeutic use | Intestine, Small - microbiology | Bacteremia - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Klebsiella Infections - microbiology | Carbapenems - therapeutic use | Intestine, Small - drug effects | Klebsiella pneumoniae - enzymology | Klebsiella pneumoniae - growth & development | Bacterial Proteins - biosynthesis | Bacteremia - pathology | Ceftazidime - therapeutic use | Challenging Clinical Cases in Antimicrobial Resistance
Journal Article
Medical Clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 475 - 496
Over the past several decades, rheumatology has directed its focus to understanding and countering the immune dysregulation underlying autoimmune diseases with... 
Biologic response modifiers | Systemic lupus erythematosus | Vasculitis | Disease-modifying antirheumatic drugs | Biologics | Rheumatoid arthritis | SYSTEMIC-LUPUS-ERYTHEMATOSUS | RITUXIMAB THERAPY | 5-AMINOSALICYLIC ACID | REFRACTORY NEUROSARCOIDOSIS | ADENOSINE RECEPTORS | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | COMBINATION TREATMENT | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Certolizumab Pegol | Rheumatic Diseases - drug therapy | Colchicine - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Polyethylene Glycols - therapeutic use | Cyclophosphamide - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Infliximab | Minocycline - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - therapeutic use | Rheumatic Diseases - immunology | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Immunoglobulin G - therapeutic use | Rituximab | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Isoxazoles - therapeutic use | Adalimumab | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2012, Volume 68, Issue 5, pp. 749 - 755
Background Frontal fibrosing alopecia (FFA) is a type of scarring hair loss primarily observed in postmenopausal women and characterized by... 
Dermatology | frontal fibrosing alopecia | scarring hair loss | lichen planopilaris | cicatricial alopecia | DIAGNOSIS | ANDROGENETIC ALOPECIA | CLUE | FINASTERIDE | LICHEN-PLANOPILARIS | PATTERN HAIR LOSS | DUTASTERIDE | DERMATOLOGY | Hydroxychloroquine - therapeutic use | Immunosuppressive Agents | Humans | Middle Aged |